Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Surveillance of hospitalized and outpatient cases of pertussis in Catalonia from 2003 to 2009.

Crespo Fernández I, Soldevila N, Carmona G, Sala MR, Godoy P, Domínguez A; Pertussis Surveillance Group of Catalonia.

Hum Vaccin Immunother. 2013 Mar;9(3):667-70. Epub 2013 Jan 9.

2.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
3.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
4.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
6.

Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.

Zamir CS, Dahan DB, Shoob H.

Vaccine. 2015 Apr 21;33(17):2073-8. doi: 10.1016/j.vaccine.2015.02.050. Epub 2015 Feb 27.

PMID:
25728322
7.

Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents.

Wolff G, Bell M, Escobar J, Ruiz S.

Vaccine. 2015 Jun 22;33(28):3228-33. doi: 10.1016/j.vaccine.2015.04.084. Epub 2015 May 5.

PMID:
25957071
8.

Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.

Sala-Farré MR, Arias-Varela C, Recasens-Recasens A, Simó-Sanahuja M, Muñoz-Almagro C, Pérez-Jové J.

Enferm Infecc Microbiol Clin. 2015 Jan;33(1):27-31. doi: 10.1016/j.eimc.2013.09.013. Epub 2013 Nov 9.

PMID:
24216286
9.

[Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].

Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romo F, Moraga-Llop FA, Arístegui-Fernández J, Goncé-Mellgren A, Bayas JM, Salleras-Sanmartí L.

Enferm Infecc Microbiol Clin. 2013 Apr;31(4):240-53. doi: 10.1016/j.eimc.2012.12.011. Epub 2013 Feb 12. Review. Spanish.

PMID:
23411362
10.

[Time for booster doses against whooping cough for 10-year-old children].

Carlsson RM, Ekholm L, Gothefors L, Granström M, Trolin I, Tegnell A.

Lakartidningen. 2005 Aug 29-Sep 4;102(35):2394-8. Review. Swedish.

PMID:
16184889
11.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
12.

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.

Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938.

PMID:
20578875
14.

Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.

Crespo I, Broner S, Soldevila N, Martínez A, Godoy P, Sala-Farré MR, Company M, Rius C, Domínguez A, Group Of Catalonia TP.

Hum Vaccin Immunother. 2015;11(1):231-5. doi: 10.4161/hv.36156. Epub 2014 Nov 1.

15.

Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

Sänger R, Behre U, Krause KH, Loch HP, Soemantri P, Herrmann D, Schmitz-Hauss E, Wolter J, Hoet B.

Eur J Pediatr. 2007 Dec;166(12):1229-36. Epub 2007 Jan 18.

PMID:
17235521
16.

Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).

Plans P, Toledo D, Sala MR, Camps N, Villanova M, Rodríguez R, Alvarez J, Solano R, García-Cenoz M, Barrabeig I, Godoy P, Minguell S.

Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):2059-2067. Epub 2016 Sep 9.

PMID:
27612470
18.

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.

Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G.

Clin Infect Dis. 2002 Jul 15;35(2):162-7. Epub 2002 Jun 19.

PMID:
12087522
19.

Pertussis in adolescents and adults: should we vaccinate?

Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

Pediatrics. 2005 Jun;115(6):1675-84.

PMID:
15930232
20.

The influence of preschool pertussis immunization on an epidemic of pertussis.

Ey JL, Duncan B, Barton LL, Buckett G.

Pediatr Infect Dis J. 1991 Aug;10(8):576-8.

PMID:
1891289

Supplemental Content

Support Center